Skip to main content
. 2020 Dec 14;14:1179548420980699. doi: 10.1177/1179548420980699

Table 1.

Demographics and patient characteristics.

Characteristics Methylprednisolone P
No (N = 38) Yes (N = 37)
Age 72.5 [34-92] 73 [48-93] .78
Male 21 (55%) 23 (62%) .54
BMI 28 [14.7-50.1] 26.6 [20.1-50.2] .42
Diabetes 20 (53%) 23 (62%) .40
Hypertension 26 (68%) 33 (89%) .03
CAD 6 (16%) 4 (11%) .52
Previous stroke 4 (11%) 3 (8%) .72
MAP < 70 at admission 17 (45%) 12 (32%) .27
GCS 14 [3-15] 15 [5-15] .05
SCR at admission 1.7 [0.6-15.7] 1.5 [0.9-10.0] .19
PaO2 at admission 67.6 [30.9-227.0] 72.0 [23.0-275.0] .37
PaO2/FiO2 ratio 97.5 [41.0-568.0] 95.9 [41.6-575.0] .81
Admission month
 March 19 (79%) 5 (21 %) .0007
 April 19 (37%) 32 (63%)
Treatment
 HCQ & AZI 25 (65%) 27 (73%) .21
 HCQ&AZI&TOC 3 (8%) 6 (16%)
 Other 10 (17%) 4 (11%)
Anticoagulation 6 (16%) 19 (51%) .001
Vassopressors 10 (26%) 8 (22%) .63
Mechanical ventilated 16 (42%) 15 (41%) .89
Hemodialysis 7 (18%) 6 (16%) .80
AKI during hospitalization 14 (37%) 14 (38%) .92

Source: Results are reported as number (percentage or range).

Abbreviations: AKI, acute kidney injury; AZI, azithromycin; BMI, body mass index; CAD, coronary artery disease; FiO2, fraction of inspired oxygen; HCQ, hydroxychloroquine; GCS, glasgow coma scale; MAP, mean arterial pressure; PaO2, partial pressure of oxygen in arterial blood; SCR, serum creatinine; TOC, tocilizumab.